Drugdu.com expert’s response: The main reasons for medical device industry to strengthen compliance management under the normalization of centralized procurement can be summarized as follows: I. Policy Drives and Strengthened Regulation 1.Normalization of Centralized Procurement Policy: The normalization of centralized procurement in the pharmaceutical industry refers to the long-term, stable, and institutionalized practice of governments or relevant agencies to conduct bulk procurement of medical products and services such as drugs and medical devices. This model aims to reduce procurement costs, improve procurement efficiency, ensure the quality and supply of drugs and medical devices, thereby meeting the basic medical needs of the people. Under the centralized procurement policy, medical device companies need to pay more attention to compliance management. 2.Strengthened Regulatory Efforts: With the promotion of numerous national policies such as medical anti-corruption, centralized procurement, and joint procurement, medical reform has been fully integrated into the overall process of deepening reforms, and regulatory ...
Drugdu.com expert’s response: FDA-recognized consensus standards for medical devices are a set of standards recognized by the U.S. Food and Drug Administration (FDA). These standards are developed by standardization organizations such as ISO, IEC, ASTM, and others, aiming to ensure the safety, effectiveness, and quality of medical devices. These standards cover various aspects of medical devices, including design, manufacturing, testing, clinical evaluation, and risk management. Ⅰ.Source of Standards: Consensus standards are usually developed by professional standard organizations like the International Organization for Standardization (ISO), International Electrotechnical Commission (IEC), and American Society for Testing and Materials (ASTM). These organizations, with the participation of a wide range of industry experts and stakeholders, create internationally recognized technical requirements and guidelines. Ⅱ.FDA Recognition: The FDA reviews and recognizes these standards, considering them to meet the FDA’s regulatory requirements. Recognized standards are listed in the FDA’s “Recognized Standards” list. Manufacturers can refer to these standards ...
Drugdu.com expert’s response: The establishment of a quality management system (QMS) for sterile in vitro diagnostic (IVD) medical devices is a complex and systematic process aimed at ensuring product safety, effectiveness, and compliance with regulatory requirements. Below is a detailed, professional step-by-step approach, referencing the Medical Device Manufacturing Practice and relevant regulatory mandates: I. Define Quality Policy and Objectives 1.Establish Quality Policy: The enterprise shall articulate a quality policy that embodies its commitment to medical device quality and patient safety. 2.Set Quality Objectives: Based on the quality policy, set specific, measurable quality objectives, such as product conformity rates and customer satisfaction levels. II. Establish Organizational Structure and Responsibilities 1.Setup Management Organization: Create a management structure tailored to medical device production, clearly defining the responsibilities and authorities of each department. 2.Appoint Management Representative: The corporate leader should designate a management representative responsible for establishing, implementing, and maintaining the QMS. 3.Clarify Responsibilities and Authorities: ...
Drugdu.com expert’s response: The medical device product registration certificate is a necessary credential for legal marketing and sales of medical device products. Its application process involves multiple stages, aiming to ensure the safety, effectiveness, and compliance of the products. Below is a detailed breakdown of the specific process for obtaining a medical device product registration certificate, divided into six phases. I. Preparation Before applying for registration, applicants need to thoroughly understand relevant national regulations and policies, including the “Regulations on the Supervision and Administration of Medical Devices” and the “Measures for the Administration of Medical Device Registration,” to ensure product compliance. At the same time, prepare necessary application materials, which include but are not limited to: 1.Enterprise Qualification Certificates: such as business licenses, medical device production licenses, etc. 2.Product Technical Data: detailing technical specifications, performance parameters, production processes, quality standards, etc. 3.Product Instructions: comprehensively describing usage methods, precautions, warning information, ...
Drugdu.com expert’s response: The qualifications required for foreign trade enterprises to act as agents for pharmaceutical exports primarily encompass the following aspects: I. Basic Qualifications 1.Foreign Trade Management Right: Foreign trade companies must possess general foreign trade import and export management rights, which serve as the fundamental prerequisite for acting as agents for pharmaceutical exports. This right permits the company to engage in or act as an agent for the import and export of various goods and technologies, except for those commodities and technologies whose import and export are restricted or prohibited by the state. 2.Registration: Foreign trade companies need to register with relevant government departments. For instance, they must register with the Ministry of Foreign Trade and Economic Cooperation to obtain import and export qualifications and with the Entry-Exit Inspection and Quarantine Bureau to acquire a quarantine registration code. These registrations are crucial steps to ensure compliance with regulations ...
Drugdu.com expert’s response: The pharmaceutical industry faces numerous challenges, including: Ⅰ.High R&D Costs: Drug development is a lengthy and expensive process, often requiring billions of dollars and many years. The risk of failure is high, with many drugs not passing clinical trials. Ⅱ.Regulatory Pressure: Drug regulatory agencies (e.g., FDA, EMA) have increasingly stringent approval requirements for new drugs, necessitating more resources for clinical trials and data collection, thus increasing the difficulty and cost of bringing new drugs to market. Ⅲ.Short Patent Protection Period: The patent protection period for new drugs is relatively short. Once the patent expires, generic drugs quickly enter the market, significantly reducing the market share and profits of the original drug. Ⅳ.Intense Market Competition: The pharmaceutical market is highly competitive, not only from other innovative drugs but also from generic drugs and biosimilars. Ⅴ.Price Pressure: Governments and the public are increasingly concerned about drug prices, especially high-priced ...
Drugdu.com expert’s response: The potential for improvement in the accuracy of medical equipment primarily manifests in the following aspects: I.Technological Advancement and Innovation 1.Genetic Testing and Analysis: By leveraging advanced genomic technologies, patient genetic information can be analyzed with greater precision, providing data support for the customization of personalized medical devices. This precise data analysis facilitates the devices’ better adaptation to individual patient differences. 2.Personalized Drug Delivery Systems: Developing delivery systems capable of precisely adjusting drug dosage and release rates based on patients’ genetic profiles and physiological states ensures the drugs’ effectiveness and safety within the body. 3.3D Printing Technology: Utilizing 3D printing to create patient-specific surgical models and prosthetics enhances surgical precision and personalization. For instance, printing prosthetics that perfectly match patients’ anatomical structures reduces surgical risks and improves recovery outcomes. 4.Real-time Physiological Monitoring: Developing medical devices capable of continuously and accurately monitoring patients’ physiological states, such as wearable ...
Drugdu.com expert’s response: Medical devices are typically categorized into three classes as follows: Class I Medical Devices: These devices pose a low level of risk and can ensure their safety and effectiveness through routine management. They are generally the basic and relatively safe medical tools commonly used in daily medical practice. Class II Medical Devices: This class of devices carries a moderate level of risk and requires stricter management measures to ensure their safety and effectiveness. They may involve certain usage risks, necessitating specialized personnel for supervision and control. Class III Medical Devices: These devices pose a high level of risk and necessitate the implementation of exceptionally stringent control measures to guarantee their safety and effectiveness. They are predominantly used for sustaining patient life, with many requiring entry into the human body, thereby harboring heightened risks that necessitate more rigorous supervision and monitoring. The classification of medical devices into these ...
Drugdu.com expert’s response: There are significant differences between the Class II medical device registration and the Class III license in various aspects, mainly embodied in the risk levels of medical devices covered, management requirements, and application procedures. Below are detailed distinctions and their respective application procedures: 1.Differences Risk Levels and Management Requirements Class II Medical Devices: Pose moderate risks and require strict control management to ensure their safety and effectiveness. The safety and efficacy of these devices must be regulated to prevent unnecessary risks to patients or users during use. Examples include X-ray machines, B-mode ultrasound scanners, microscopes, biochemical analyzers, etc. Class III Medical Devices: Represent the highest level of medical devices and are subject to the strictest control. These devices are often implanted into the human body or used to support or sustain life, and their failure can cause severe harm or even death to patients. Therefore, their safety ...
Drugdu.com expert’s response: In the medical device industry, there are numerous reports worthy of attention, typically issued by industry research institutions, consulting firms, or relevant government departments. These reports aim to provide comprehensive insights into the current state of the industry, market size, development trends, competitive landscape, and more. Below are some of the most noteworthy medical device industry reports: 1.Global and China Medical Device Market Research Reports Issued by: Reputable global consulting firms such as McKinsey, Boston Consulting Group , Deloitte, among others. Content Overview: These reports comprehensively cover the overall size, growth rates, market segments (including diagnostic equipment, therapeutic devices, consumables, etc.), key market drivers, regional market analyses, competitive landscapes, and future trend forecasts for both the global and Chinese medical device markets. Value: Provide industry players with a holistic view of both global and Chinese markets, facilitating the formulation of internationalization and localization strategies. 2.Medical Device Technology ...
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.